Skip to main content

Table 2 Baseline characteristics of the female and male elderly MPM patients

From: Clinical-pathological characteristics and prognostic factors for malignant peritoneal mesothelioma in the elderly

Variable

Male

N = 391 (58.80%)

Female

N = 274 (41.20%)

P value

Age at diagnosis

73.68 ± 6.21

75.28 ± 7.06

0.002

Race

  

0.083

White

369 (94.37%)

247 (90.15%)

 

Black

10 (2.56%)

14 (5.11%)

 

Asian or Pacific Islander

12 (3.07%)

11 (4.01%)

 

American Indian/Alaska Native

0

2 (0.73%)

 

Insurance status

  

0.838

Insured

137 (35.04%)

102 (37.23%)

 

Uninsured

2 (0.51%)

1 (0.36%)

 

Unknown

252 (64.45%)

171 (62.41%)

 

Marital status

  

 < 0.001

Married

287 (73.40%)

111 (40.51%)

 

Unmarried

99 (25.32%)

157 (57.30)

 

Unknown

5 (1.28%)

6 (2.19%)

 

Site

  

0.878

Peritoneum

369 (94.37%)

261 (95.26%)

 

Retroperitoneum

20 (5.12%)

12 (4.38%)

 

Ovarlapping lesion of retroperitoneum and peritoneum

2 (0.51%)

1 (0.36%)

 

Histology

  

0.531

Epithelioid

116 (29.67%)

79 (28.83%)

 

Biphasic

11 (2.81%)

8 (2.92%)

 

Sarcomatoid

8 (2.05%)

11 (4.01%)

 

Unknown

256 (65.47%)

176 (64.23%)

 

Grade

  

0.274

Well differentiated

14 (3.58%)

19 (6.93%)

 

Moderately differentiated

7 (1.79%)

4 (1.46%)

 

Poorly differentiated

27 (6.91%)

21 (7.66%)

 

Undifferentiated

5 (1.28%)

6 (2.19%)

 

Unknown

338 (86.44%)

224 (81.76%)

 

Stage

  

0.190

Localized

32 (8.18%)

36 (13.14%)

 

Regional

58 (14.83%)

37 (13.50%)

 

Distant

251 (64.19%)

163 (59.49%)

 

Unknown

50 (12.79)

38 (19.87%)

 

Surgery

  

 < 0.001

Cancer-directed surgery done

100 (25.58%)

122 (44.53%)

 

No cancer-directed surgery

284 (72.63%)

146 (53.28%)

 

Radiotherapy

  

0.605

Yes

10 (2.56%)

5 (1.82%)

 

No/unknown

381 (97.44%)

269 (98.18%)

 

Chemotherapy

  

0.342

Yes

178 (45.78%)

115 (42.97%)

 

No/unknown

212 (54.22%)

159 (58.03%)

 
  1. Significant P values shown in bold
  2. MPM, malignant peritoneal mesothelioma